We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
(+10%)
Cap. Flow
+$368M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$203M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$91.1M |
| 3 |
PG&E
PCG
|
+$57.7M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$53.7M |
| 5 |
Boston Scientific
BSX
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$67M |
| 2 |
iShares MSCI India ETF
INDA
|
+$55.1M |
| 3 |
Apple
AAPL
|
+$50.9M |
| 4 |
Intuit
INTU
|
+$43.3M |
| 5 |
Lowe's Companies
LOW
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.3% |
| 2 | Technology | 11.38% |
| 3 | Healthcare | 10.73% |
| 4 | Industrials | 10.27% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
626
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.65M | 0.03% |
113,256
-2,076
| -2% | -$29.2K |
|
627
HubSpot
HUBS
$10.5B
| $1.65M | 0.03% |
+18,658
| New | +$1.57M |
|
|
GBT
628
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.65M | 0.03% |
+41,894
| New | +$1.56M |
|
629
International Paper
IP
$22.3B
| $1.65M | 0.03% |
29,995
+12,226
| +69% | +$656K |
|
630
Applied Optoelectronics
AAOI
$8.04B
| $1.64M | 0.03% |
+43,290
| New | +$1.91M |
|
|
COHR
631
DELISTED
Coherent Inc
COHR
| $1.63M | 0.03% |
+5,790
| New | +$1.61M |
|
632
Ichor Holdings
ICHR
$3.02B
| $1.63M | 0.03% |
+66,387
| New | +$1.88M |
|
633
Hawaiian Electric Industries
HE
$2.33B
| $1.63M | 0.03% |
45,066
+13,265
| +42% | +$480K |
|
634
Public Service Enterprise Group
PEG
$39.8B
| $1.63M | 0.03% |
+31,600
| New | +$1.59M |
|
635
East-West Bancorp
EWBC
$17.9B
| $1.62M | 0.03% |
26,700
+2,445
| +10% | +$146K |
|
636
Realty Income
O
$61.2B
| $1.62M | 0.03% |
+29,300
| New | +$1.59M |
|
637
Cencora
COR
$60.3B
| $1.62M | 0.03% |
+17,619
| New | +$1.46M |
|
638
McCormick & Company Non-Voting
MKC
$13.4B
| $1.61M | 0.03% |
31,542
-64,666
| -67% | -$3.22M |
|
639
iShare MSCI Eurozone ETF
EZU
$9.41B
| $1.6M | 0.03% |
+36,900
| New | +$1.6M |
|
|
CSRA
640
DELISTED
CSRA Inc.
CSRA
| $1.59M | 0.03% |
+53,235
| New | +$1.61M |
|
641
Helen of Troy
HELE
$663M
| $1.59M | 0.03% |
16,521
+7,853
| +91% | +$723K |
|
642
Visa
V
$677B
| $1.59M | 0.03% |
13,965
-4,729
| -25% | -$522K |
|
|
MNDT
643
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.59M | 0.03% |
111,994
-35,967
| -24% | -$547K |
|
|
CLGX
644
DELISTED
Corelogic, Inc.
CLGX
| $1.59M | 0.03% |
34,392
+29,989
| +681% | +$1.39M |
|
645
CoreCivic
CXW
$3.1B
| $1.58M | 0.03% |
+70,348
| New | +$1.69M |
|
646
Wintrust Financial
WTFC
$10.7B
| $1.58M | 0.03% |
19,180
+7,738
| +68% | +$623K |
|
|
MIK
647
DELISTED
Michaels Stores, Inc
MIK
| $1.57M | 0.03% |
+65,081
| New | +$1.35M |
|
|
SFIX
648
Stitch Fix
SFIX
$478M
| $1.57M | 0.03% |
+60,677
| New | +$1.38M |
|
649
Donaldson
DCI
$10.8B
| $1.56M | 0.03% |
31,959
-31,785
| -50% | -$1.52M |
|
650
Enanta Pharmaceuticals
ENTA
$372M
| $1.55M | 0.03% |
+26,466
| New | +$1.33M |
|
Similar funds
Squarepoint's Q4 2017 Portfolio in Review
As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.
- Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
- Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
- Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
- Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
- Squarepoint opened 949 new positions and closed 486 in Q4 2017.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.
Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.